In this article, Pawel Stanczak, Director of Formulation Development at Tanvex CDMO, explores the critical technologies and processes that set Tanvex’s formulation development capabilities apart, including:
Innovative Platforms for Rapid, Accurate Development
Faster, more accurate, and cost-effective biophysical and analytical screening platforms that are revolutionizing the approach to biopharmaceutical formulation
Interdisciplinary Expertise and Quality-by-Design
The importance of a quality-by-design approach for elevating interactions between excipients and the drug substance to ensure the highest stability and patient-centric delivery methods
Harnessing the Power of AI and Machine Learning
The potential of artificial intelligence and machine learning in predicting optimal formulations for biologic drugs.
Access the article
"*" indicates required fields